SLN
Silence Therapeutics·NASDAQ
--
--(--)
--
--(--)
SLN fundamentals
Silence Therapeutics (SLN) released its earnings on Nov 6, 2025: revenue was 159.00K (YoY -89.04%), missed estimates; EPS was -0.15 (YoY +38.20%), beat estimates.
Revenue / YoY
159.00K
-89.04%
EPS / YoY
-0.15
+38.20%
Report date
Nov 6, 2025
Earnings
EPS
Revenue
Revenue & Expenses
SLN has released its 2025 Q4 earnings report, with revenue of 34.00K, reflecting a YoY change of -99.87%, and net profit of -11.77M, showing a YoY change of -195.68%. The Sankey diagram below clearly presents SLN's revenue sources and cost distribution.
Key Indicators
Silence Therapeutics (SLN) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Silence Therapeutics (SLN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Silence Therapeutics (SLN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Silence Therapeutics (SLN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Silence Therapeutics (SLN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Silence Therapeutics (SLN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Silence Therapeutics's revenue and profit?What is the revenue and EPS growth rate for Silence Therapeutics year over year?What guidance did Silence Therapeutics's management provide for the next earnings period?What were the key takeaways from Silence Therapeutics's earnings call?What is Silence Therapeutics's gross profit margin?What is Silence Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Silence Therapeutics’s earnings call?What does Silence Therapeutics do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
